• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

2009 PharmExec Top 50

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive-05-01-2009
Volume 0
Issue 0

We leap tall buildings to bring you the definitive guide to the world's top pharmaceutical companies.

External Link - article-597526.pdf

Articles in this issue
i1-597225-1408649264472.jpg
Compensation Overkill
i4-597232-1408649229820.jpg
Ad(Ventures) in Pharmaland
2009 PharmExec Top 50
2009 PharmExec Top 50
i1-597229-1408649244520.jpg
Behavior and the Bottom Line
i1-597223-1408649271888.jpg
A Day Late and a Dollar Short
i4-597226-1408649259564.jpg
The Shakeout
i4-597235-1408649213816.jpg
Bank on IT
i3_t-597221-1408649282373.jpg
Weathering the Storm
i1-597230-1408649240021.jpg
Compared to What?
i1-597233-1408649224715.jpg
Another Dimension
Recent Videos
Related Content
Kirsten Jacobs

The Lifespan of Mature Drugs in 2025: Q&A with Kirsten Jacobs

Mike Hollan
December 18th 2024
Article

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Seeking More Value, Less Cost

Seeking More Value, Less Cost

Michael Christel
December 17th 2024
Article

The biosimilars market in the US is on the rise, but barriers to greater adoption remain.

Dealmaking Dormant No More

Dealmaking Dormant No More

Mike Hollan
December 17th 2024
Article

Unleashed demand over the past year characterizes the M&A picture in pharma.

The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024
Article

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.